NatalizumabHerpes simplex virus (type I and type II) and varicella zoster virus: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1877卷 / 1期

关键词：

D O I：

10.1007/s40278-021-03879-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：309 / 309

相关论文

共 50 条

[1] NatalizumabHerpes simplex virus type 1 encephalitis: case report
Reactions Weekly, 2012, 1415 (1) : 37 - 37
[2] NatalizumabHerpes simplex virus encephalitis: case report
Reactions Weekly, 2016, 1629 (1) : 180 - 180
[3] NatalizumabHerpes simplex virus 2 meningitis: case report
Reactions Weekly, 2011, 1365 (1) : 33 - 33
[4] ThalidomideFirst report of fatal herpes simplex virus and varicella zoster virus coinfection: case report
Reactions Weekly, 2002, 914 (1) : 11 - 11
[5] Cyclophosphamide/fludarabine/rituximabHerpes simplex virus type I and type II lymphadenitis: case report
Reactions Weekly, 2025, 2042 (1) : 137 - 137
[6] Varicella-zoster-virus-vaccineDisseminated varicella zoster virus infection: case report
Reactions Weekly, 2020, 1797 (1) : 229 - 229
[7] Varicella-zoster-virus-vaccineReactivation of varicella zoster virus infection: case report
Reactions Weekly, 2023, 1951 (1) : 315 - 315
[8] A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation
Kennedy, Peter G. E.
Rovnak, Joel
Badani, Hussain
Cohrs, Randall J.
JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 1581 - 1602
[9] Varicella zoster virus vaccine liveBilateral acute retinal necrosis secondary to wild-type varicella zoster virus reactivation: case report
Reactions Weekly, 2017, 1681 (1) : 350 - 350
[10] Varicella zoster virus vaccineVaricella zoster virus infection: case report
Reactions Weekly, 2017, 1666 (1) : 284 - 284

← 1 2 3 4 5 →